Brief: Fulcrum Therapeutics Q2 Basic EPS USD -0.38
03/08/2023 12:01
Aug 03 (Reuters) - Fulcrum Therapeutics Q2 operating income USD -27.292 million. * Q2 net income USD -23.783 million * Q2 operating expenses USD 28.172 million * Q2 collaboration revenue USD 880 thousand
Recent news on Fulcrum Therapeutics
See all newsFulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback